HemaSphere
(Jun 2022)
S223: LATE CARDIOVASCULAR TOXICITY AFTER HIGH-DOSE CHEMOTHERAPY FOR LYMPHOMA: A DANISH POPULATION-BASED STUDY
- S. Husby,
- J. Baech,
- T. Trab,
- J. Gørløv,
- J. M. Jørgensen,
- S. Gudbrandsdottir,
- M. T. Severinsen,
- K. Grønbæk,
- T. S. Larsen,
- P. Brown,
- L. H. Jakobsen,
- K Kragholm,
- T. C. El-Galaly
Affiliations
- S. Husby
- 1 Hematology, Aalborg University hospital, Copenhagen N
- J. Baech
- 2 Hematology, Aalborg University hospital, Aalborg
- T. Trab
- 2 Hematology, Aalborg University hospital, Aalborg
- J. Gørløv
- 3 Hematology, Rigshospitalet, Copenhagen N
- J. M. Jørgensen
- 4 Hematology, Aarhus University Hospital, Aarhus
- S. Gudbrandsdottir
- 5 Hematology, Zealand University Hospital, Roskilde
- M. T. Severinsen
- 2 Hematology, Aalborg University hospital, Aalborg
- K. Grønbæk
- 3 Hematology, Rigshospitalet, Copenhagen N
- T. S. Larsen
- 6 Hematology, Odense University Hospital, Odense
- P. Brown
- 3 Hematology, Rigshospitalet, Copenhagen N
- L. H. Jakobsen
- 2 Hematology, Aalborg University hospital, Aalborg
- K Kragholm
- 7 Cardiology, Aalborg University hospital, Aalborg, Denmark
- T. C. El-Galaly
- 2 Hematology, Aalborg University hospital, Aalborg
- DOI
-
https://doi.org/10.1097/01.HS9.0000843784.09535.d5
- Journal volume & issue
-
Vol. 6
pp.
124
– 125
WeChat QR code